Lewis Gazzard

1.2k citations
14 papers · 495 indexed · h-index 11
Topics
Cancer therapeutics and mechanisms (3 papers)DNA Repair Mechanisms (2 papers)Alkaloids: synthesis and pharmacology (2 papers)

In The Last Decade

Lewis Gazzard

13 papers receiving 481 citations

Peers

Lewis Gazzard
Comparison fields: 5 of 71
  • Molecular Biology 264
  • Organic Chemistry 181
  • Oncology 81
  • Radiology, Nuclear Medicine and Imaging 43
  • Pharmacology 40
Replace Daniel J. Sall with:
Daniel J. Sall United States
Shigehiro Asano Japan
Jianqi Li China
Aimee K. Bence United States
Paul Beswick United Kingdom
Sarah H. Gardner United States
Martyn Inman United Kingdom
Katerina Leftheris United States
Firoz A. Jaipuri United States
Lewis Gazzard relative to Daniel J. Sall United States Daniel J. Sall's profile →
Citations per field
00.5×3.6×
Daniel J. Sall · 1×
Citations per year

Countries citing papers authored by Lewis Gazzard

Since Specialization
Citations

This map shows the geographic impact of Lewis Gazzard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis Gazzard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis Gazzard more than expected).

Fields of papers citing papers by Lewis Gazzard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis Gazzard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis Gazzard. The network helps show where Lewis Gazzard may publish in the future.

Co-authorship network of co-authors of Lewis Gazzard

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis Gazzard. A scholar is included among the top collaborators of Lewis Gazzard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis Gazzard. Lewis Gazzard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 10
3 4
4 24
5 34
6 10
7 15
8 22
9 15
10 196
11 78
12 22
13 37
14 28

About Lewis Gazzard

Lewis Gazzard is a scholar working on Biological Psychiatry, Pharmaceutical Science and Biochemistry, having authored 14 papers that have together received 495 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), DNA Repair Mechanisms (2 papers) and Alkaloids: synthesis and pharmacology (2 papers). The work is most often cited by research in Biological Psychiatry (27 citations), Organic Chemistry (181 citations) and Pharmaceutical Science (28 citations). Lewis Gazzard has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Cary D. Austin, Suzie J. Scales, Richard H. Scheller, Xiaohui Wen, Christopher A. Nelson, William B. Motherwell, V. Lynch, Philip Magnus, L. Hobson and Andrew H. Payne. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Biotechnology and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026